SCHEDULE 13G FOR HERBERT AND EURETTA HASTINGS

Company

Anika Therapeutics, Inc.

Filed

February 4, 2000

Accession Number

0001017062-00-000128

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →